CD44 and cancer: One study separated CSCs with single-cell assay of human LUAD cancer cells (A549), with CD44+/CD24−/phenotype characteristics, special stemness-related gene expression, and Hoechst 33342 dye efflux assay, and the secondary protein structure of CSCs changed when compared to non-stem cancer cells (24).